Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

rM-CSF efficiently replaces L929 in generating mouse and rat bone marrow-derived macrophages for in vitro functional studies of immunity to intracellular bacteria.

Rice HM, Rossi AP, Bradford MK, Elkins KL, De Pascalis R.

J Immunol Methods. 2019 Nov 2:112693. doi: 10.1016/j.jim.2019.112693. [Epub ahead of print]

PMID:
31689421
2.

Mechanically induced Helfrich-Hurault effect in a confined lamellar system with finite surface anchoring.

De Pascalis R.

Phys Rev E. 2019 Jul;100(1-1):012705. doi: 10.1103/PhysRevE.100.012705.

PMID:
31499922
3.

Soft metamaterials with dynamic viscoelastic functionality tuned by pre-deformation.

Parnell WJ, De Pascalis R.

Philos Trans A Math Phys Eng Sci. 2019 May 6;377(2144):20180072. doi: 10.1098/rsta.2018.0072.

4.

A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.

De Pascalis R, Hahn A, Brook HM, Ryden P, Donart N, Mittereder L, Frey B, Wu TH, Elkins KL.

PLoS One. 2018 May 25;13(5):e0198140. doi: 10.1371/journal.pone.0198140. eCollection 2018.

5.

GM-CSF has disparate roles during intranasal and intradermal Francisella tularensis infection.

Kurtz SL, Bosio CM, De Pascalis R, Elkins KL.

Microbes Infect. 2016 Dec;18(12):758-767. doi: 10.1016/j.micinf.2016.07.003. Epub 2016 Jul 27.

PMID:
27475899
6.

Progress, challenges, and opportunities in Francisella vaccine development.

Elkins KL, Kurtz SL, De Pascalis R.

Expert Rev Vaccines. 2016 Sep;15(9):1183-96. doi: 10.1586/14760584.2016.1170601. Epub 2016 May 3. Review.

PMID:
27010448
7.

Activities of Murine Peripheral Blood Lymphocytes Provide Immune Correlates That Predict Francisella tularensis Vaccine Efficacy.

De Pascalis R, Mittereder L, Kennett NJ, Elkins KL.

Infect Immun. 2016 Mar 24;84(4):1054-1061. doi: 10.1128/IAI.01348-15. Print 2016 Apr.

8.

Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice.

De Pascalis R, Mittereder L, Chou AY, Kennett NJ, Elkins KL.

PLoS One. 2015 May 14;10(5):e0126570. doi: 10.1371/journal.pone.0126570. eCollection 2015.

9.

On nonlinear viscoelastic deformations: a reappraisal of Fung's quasi-linear viscoelastic model.

De Pascalis R, Abrahams ID, Parnell WJ.

Proc Math Phys Eng Sci. 2014 Jun 8;470(2166):20140058.

10.

Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).

De Pascalis R, Chou AY, Ryden P, Kennett NJ, Sjöstedt A, Elkins KL.

MBio. 2014 Apr 8;5(2):e00936. doi: 10.1128/mBio.00936-13.

11.

Epicutaneous model of community-acquired Staphylococcus aureus skin infections.

Prabhakara R, Foreman O, De Pascalis R, Lee GM, Plaut RD, Kim SY, Stibitz S, Elkins KL, Merkel TJ.

Infect Immun. 2013 Apr;81(4):1306-15. doi: 10.1128/IAI.01304-12. Epub 2013 Feb 4.

12.

Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS.

De Pascalis R, Chou AY, Bosio CM, Huang CY, Follmann DA, Elkins KL.

PLoS Pathog. 2012 Jan;8(1):e1002494. doi: 10.1371/journal.ppat.1002494. Epub 2012 Jan 19.

13.

Analytical and dimensional morphometry in early diagnosis cutaneous melanoma with dermoscopic images.

Ricco R, Lettini T, Arpaia N, Valente T, Ingravallo G, Vurro ML, De Pascalis R, Delfino VP.

Anal Quant Cytol Histol. 2011 Aug;33(4):229-35.

PMID:
21980628
14.

Analysis of the Fc gamma receptor-dependent component of neutralization measured by anthrax toxin neutralization assays.

Verma A, Ngundi MM, Meade BD, De Pascalis R, Elkins KL, Burns DL.

Clin Vaccine Immunol. 2009 Oct;16(10):1405-12. doi: 10.1128/CVI.00194-09. Epub 2009 Aug 5.

15.

T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria.

Collazo CM, Meierovics AI, De Pascalis R, Wu TH, Lyons CR, Elkins KL.

Infect Immun. 2009 May;77(5):2010-21. doi: 10.1128/IAI.01322-08. Epub 2009 Feb 23.

16.

NK cells activated in vivo by bacterial DNA control the intracellular growth of Francisella tularensis LVS.

Elkins KL, Colombini SM, Krieg AM, De Pascalis R.

Microbes Infect. 2009 Jan;11(1):49-56. doi: 10.1016/j.micinf.2008.10.005. Epub 2008 Oct 22.

PMID:
18992838
17.

Diverse myeloid and lymphoid cell subpopulations produce gamma interferon during early innate immune responses to Francisella tularensis live vaccine strain.

De Pascalis R, Taylor BC, Elkins KL.

Infect Immun. 2008 Sep;76(9):4311-21. doi: 10.1128/IAI.00514-08. Epub 2008 Jun 23.

18.

SDR grafting--a new approach to antibody humanization.

Kashmiri SV, De Pascalis R, Gonzales NR, Schlom J.

Methods. 2005 May;36(1):25-34. Review.

PMID:
15848072
19.

Minimizing the immunogenicity of antibodies for clinical application.

Gonzales NR, De Pascalis R, Schlom J, Kashmiri SV.

Tumour Biol. 2005 Jan-Feb;26(1):31-43. Review.

PMID:
15741769
20.

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide.

Lutsiak ME, Semnani RT, De Pascalis R, Kashmiri SV, Schlom J, Sabzevari H.

Blood. 2005 Apr 1;105(7):2862-8. Epub 2004 Dec 9.

PMID:
15591121
21.

SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity.

Gonzales NR, Padlan EA, De Pascalis R, Schuck P, Schlom J, Kashmiri SV.

Mol Immunol. 2004 Jul;41(9):863-72.

PMID:
15261458
22.

Developing a minimally immunogenic humanized antibody by SDR grafting.

Kashmiri SV, De Pascalis R, Gonzales NR.

Methods Mol Biol. 2004;248:361-76. No abstract available.

PMID:
14970508
23.
24.

Minimizing immunogenicity of the SDR-grafted humanized antibody CC49 by genetic manipulation of the framework residues.

Gonzales NR, Padlan EA, De Pascalis R, Schuck P, Schlom J, Kashmiri SV.

Mol Immunol. 2003 Oct;40(6):337-49.

PMID:
14522015
25.

Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.

De Pascalis R, Iwahashi M, Tamura M, Padlan EA, Gonzales NR, Santos AD, Giuliano M, Schuck P, Schlom J, Kashmiri SV.

J Immunol. 2002 Sep 15;169(6):3076-84.

26.

Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancer.

Kass ES, Greiner JW, Kantor JA, Tsang KY, Guadagni F, Chen Z, Clark B, De Pascalis R, Schlom J, Van Waes C.

Cancer Res. 2002 Sep 1;62(17):5049-57.

27.

Generation and characterization of a novel single-gene-encoded single-chain immunoglobulin molecule with antigen binding activity and effector functions.

Lee HS, Shu L, De Pascalis R, Giuliano M, Zhu M, Padlan EA, Hand PH, Schlom J, Hong HJ, Kashmiri SV.

Mol Immunol. 1999 Jan;36(1):61-71.

PMID:
10369421
28.

Performance characteristics of an enzyme-linked immunosorbent assay for determining salivary immunoglobulin G response to Helicobacter pylori.

De Pascalis R, Del Pezzo M, Nardone G, Budillon G, Lavitola A.

J Clin Microbiol. 1999 Feb;37(2):430-2.

29.

Detection of IgG and IgA against the mycobacterial antigen A60 in patients with extrapulmonary tuberculosis.

Alifano M, De Pascalis R, Sofia M, Faraone S, Del Pezzo M, Covelli I.

Thorax. 1998 May;53(5):377-80.

30.

Effects of bicyclomycin on RNA- and ATP-binding activities of transcription termination factor Rho.

Carrano L, Bucci C, De Pascalis R, Lavitola A, Manna F, Corti E, Bruni CB, Alifano P.

Antimicrob Agents Chemother. 1998 Mar;42(3):571-8.

31.

Evaluation of IgA-mediated humoral immune response against the mycobacterial antigen P-90 in diagnosis of pulmonary tuberculosis.

Alifano M, De Pascalis R, Sofia M, Faraone S, Del Pezzo M, Covelli I.

Chest. 1997 Mar;111(3):601-5.

PMID:
9118694
32.

Detection of IgA against the mycobacterial antigen A60 in serum and saliva in patients with active pulmonary tuberculosis: preliminary results.

Del Pezzo M, Alifano M, Faraone S, Battiloro R, De Pascalis R, Lavitola A.

New Microbiol. 1996 Oct;19(4):363-7.

PMID:
8914139

Supplemental Content

Loading ...
Support Center